Review the important dates below for 2023 IKCS: Europe
| Abstract Submissions Open | December 2022 |
| Program-At-A-Glance | January 2023 |
| Registration Now Open | December 2022 |
| Hotel Reservation Information | December 2022 |
| Program Details and Speakers Released | January 2023 |
| Abstract Submission Deadline (all complete Regular, TPS, and Case Report submissions, and all LBA Placeholders due at this time) | 31 January 2023 at 23:59 PST |
| LBA Submission Deadline (LBA Placeholder required by August 2 deadline) | 22 February 2023 at 12:00 (Noon) PST (placeholder required by 31 January) |
| Abstract Notifications Sent to Lead Authors | Mid-February 2023 |
| Early Symposium Registration Deadline | 8 March 2023 at 23:59 PST |
| Abstract Withdrawal Deadline (Withdrawal requests must be submitted by the Lead Author to [email protected]) | 8 March 2023 at 23:59 PST |
| Abstract Titles Released | Mid-March 2023 |
| Deadline to cancel Hotel Reservations without fees | TBD |
| Presentation Slides Due | 23 March 2023 |
| Poster Uploads Due | 5 April 2023 |
| Abstracts Released | 17 April 2023 at 16:00 BST |
| Post-Meeting On Demand Available | Beginning of May 2023 |
| Meeting Dates | 21-22 April 2023 |
| Category | Early Registration Rate (Register by March 23, 2023 at 23:59 GMT) | Regular Registration Rate (After March 23, 2023) | Post-Event (April 25, 2023 to December 31, 2023) |
|---|---|---|---|
| In-person Physician/Scientist | £335 | £445 | N/A |
| Group In-person Physician/Scientist (this rate includes 1 in-person Physician/Scientist registration and 3 post-meeting on-demand access registrations) | £550 | £700 | N/A |
| In-person Allied Health Professional | £232 | £325 | N/A |
| In-person Physician In-Training | £235 | £325 | N/A |
| In-person Patient/Advocate/Caregiver | Complimentary* | £75 | N/A |
| In-person Industry | £445 | £585 | N/A |
| In-person Media | Complimentary** | Complimentary** | N/A |
| Post-Event On-Demand Access | £315 | £315 | £315 |
Meeting Venue: Edinburgh International Conference Centre
Venue Address: The Exchange, 150 Morrison St, Edinburgh EH3 8EE, United Kingdom
Abstract Submissions are open now!
Follow the guidelines below to submit an abstract to IKCS: Europe.
Abstract Submission Types:
Abstract Sections:
Abstract Policies:
Abstracts in the following categories will be considered for presentation:
Abstracts submitted in this category are Phase I-IV trials, or original research that could impact practice and standard of care. LBA Abstracts should be studies where results and conclusions are not yet available by the 31 January deadline, but will be available by the 22 February 12:00 (Noon) PST deadline.
Abstracts submitted in this category must have a placeholder submission (all components except for Results and Conclusions sections) received by the 31 January 2023 23:59 PST abstract submission deadline.
Lead authors will receive separate instructions to complete LBA placeholder submissions by the 22 February LBA deadline.
Abstracts submitted in this category are ongoing and should not include data, results, nor conclusions.
TPS abstracts are open, enrolling, or ongoing and have not reached any protocol-specific endpoints for analysis, and consequently will only require the completion of the Background and Methods sections.
Abstracts in all phases of clinical research (I, II, III, IV) may be submitted.
TPS Abstracts, if accepted, are eligible for Poster Presentation. TPS abstracts are not eligible for Oral Presentation.
Abstracts will be reviewed by the IKCS: Europe Scientific Planning Committee. Abstract notifications will be sent to lead authors in February 2023.
Merit Awards are given to early-career abstract authors within 5 years of completing residency of high-quality submitted abstracts. To apply for a Merit Award, the presenting author should select “Yes” to the question “would you like to apply for a merit award?” The presenting author is required to upload a CV/Resume and a Letter of Support from their training program supervisor substantiating the applicant’s good standing in their training program.
Merit Award Eligibility Requirements:
The IKCS Scientific Planning Committee will select recipients to receive a merit award for the best original submissions.
*Please note: Trials in Progress presentations will not be eligible to receive a merit award.
All accepted abstracts and lead authors are requested to present in-person at IKCS: Europe. Accepted abstracts will be displayed at the live meeting and electronic versions will be available online for post-meeting on-demand access.
All Abstract Presenters must register for the conference.
Oral Abstract Presenter Guidelines
Abstract texts will be released on the hybrid meeting platform on 17 April 2023 at 16:00 BST.
Poster Presentations will become available beginning 21 April 2023. PDF versions of presentation slides will become available during the specific session for the presentation.
Please contact [email protected].
Jointly provided by The France Foundation and the Kidney Cancer Association.
Target Audience: This educational activity is intended for medical oncologists and urologists who treat patients with kidney cancer. Fellows, trainees, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of kidney cancer are invited to participate.
Statement of Need: Education and interaction surrounding the space of renal cell carcinoma are paramount to improving patient care. This program is targeted to physicians, advocates, researchers, and care team members to help promote learning and collaboration for advancement in the renal cancer space.
Educational Learning Activity Objectives: Upon completion of this course, the participants should be able to:
Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The France Foundation and the Kidney Cancer Association. The France Foundation is accredited by ACCME to provide continuing medical education for physicians.
Credit Designation:
Physicians: The France Foundation designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The 2022 IKCS: Europe – International Kidney Cancer Symposium, Antwerp, Belgium, 22/04/2022- 24/04/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 14 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama–assn.org/education/earn–credit–participation–international–activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Thank you to our 2023 IKCS: Europe Planners!
2023 IKCS: Europe Planning Committee disclosures will be available here in January 2023.
Speaker PPT Slide Presentations are due in the Faculty/Speaker Portal by 22 March, 2023.
Meeting Format: 2023 IKCS: Europe will be a live event offering in-person participation for meeting attendees. On-demand Virtual access will be available post-meeting. Sessions will be recorded, but will not be live-streamed. Faculty are expected to attend in-person in, however, reasonable adjustments may be considered due to COVID-19 related travel restrictions.
Conflict of Interest Disclosure: Confirmation of any faculty invitation requires agreement to abide by Conflict of Interest procedures in addition to policies set forth by the Kidney Cancer Association, The France Foundation, and the Accreditation Council for Continuing Medical Education (ACCME) for content and presentation. All Faculty are required to submit a full disclosure of financial interests with commercial entities. All Conflict of Interest Disclosures will be reviewed by The France Foundation for final approval and participation in the program. Failure to submit a Conflict of Interest Disclosure will prohibit participation in the program.
Session Preparation: Speakers should upload their presentation slides by 22 March 2023. Slides will be reviewed by Session Chairs/Moderators and CME regulators to ensure compliance with CME guidelines, minimize content overlap between sessions, and help presentations contribute to a cohesive and educational session. Speakers may receive recommendations for slide adjustments. Speakers who are only able to participate virtually will receive instructions to pre-record their presentations prior to the meeting, along with instructions to participate in the live panel Q+A at the end of the session.
Download the PPT Template– Available January 2023
Faculty Benefits: Faculty may be eligible for benefits including Registration, Hotel accommodation, and travel assistance. Faculty will receive details and instructions for meeting arrangements directly via email. If you have questions please contact [email protected]